[Evaluation of effects of L-thyroxine therapy in differentiated thyroid carcinoma on the cardiovascular system --prospective study].
Patients with differentiated thyroid carcinoma are treated by thyreoidectomy, followed by radioiodine treatment. A life-time suppressive therapy with L-thyroxine is also indicated. However, it may cause cardiovascular side effects. The aim of the study was a prospective evaluation of the left ventricle hypertrophy in patients treated with suppressive doses of thyroxine. A significant rise in left ventricular mass and mass index was noted during the first year of therapy and could be prevented by a simultaneous treatment with low doses of bisoprolol.
Zakładu Medycyny Nuklearnej i Endokrynologii Onkologicznej Centrum Onkologii-Instytut im. M. Skłodowskiej-Curie, Oddział w Gliwicach.
G
G
Matuszewska
J
J
Roskosz
J
J
Włoch
B
B
Jurecka-Tuleja
K
K
Hasse-Lazar
P
P
Kowalczyk
B
B
Jarzab
D005260:Female; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000139:chemically induced*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D013965:Thyroidectomy; D013974:Thyroxine / Q000009:adverse effects* / Q000627:therapeutic use*
D007457:Iodine Radioisotopes; D013974:Thyroxine